Astera Labs (NASDAQ:ALAB) Shares Down 5.3% Following Insider Selling

Key Points

• Astera Labs shares fell 5.3% to $324.11 after director Stefan Dyckerhoff sold 12,499 shares for approximately $4.7 million under a pre-arranged Rule 10b5-1 trading plan.
• Analyst sentiment remains positive overall, with 11 Buy and 10 Hold ratings, producing a “Moderate Buy” consensus and an average price target of $348.33.
• The company reported strong recent operating results, including 104.5% year-over-year revenue growth, $0.80 quarterly EPS versus $0.69 expected, and $392.4 million in revenue versus $360.85 million estimated.

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) fell 5.3% on Monday following insider selling activity. The company traded as low as $320.23 and last traded at $324.11. 3,480,070 shares changed hands during trading, a decline of 33% from the average daily volume of 5,182,813 shares. The stock had previously closed at $342.21.

Specifically, Director Stefan Dyckerhoff sold 8,994 shares of the stock in a transaction on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the transaction, the director owned 2,648 shares in the company, valued at $995,806.88. This represents a 77.25% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 3,505 shares of the firm's stock in a transaction on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total transaction of $1,318,090.30. Following the transaction, the director owned 47,019 shares in the company, valued at $17,681,965.14. This represents a 6.94% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Weiss Ratings upgraded shares of Astera Labs from a "hold (c)" rating to a "buy (b-)" rating in a report on Thursday. Zacks Research downgraded shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 5th. Susquehanna raised their target price on Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a report on Friday, July 31st. Stifel Nicolaus boosted their price target on Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a research report on Wednesday, June 24th. Finally, Bank of America boosted their price target on Astera Labs from $240.00 to $450.00 and gave the stock a "neutral" rating in a research report on Tuesday, June 23rd. Eleven analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $348.33.

Astera Labs Stock Down 5.3%

The company has a market cap of $56.23 billion, a P/E ratio of 160.45 and a beta of 3.68. The stock's 50-day moving average price is $317.44 and its 200 day moving average price is $291.57.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs's revenue was up 104.5% compared to the same quarter last year. During the same period last year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts expect that Astera Labs, Inc. will post 2.70 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Astera Labs

A number of institutional investors have recently made changes to their positions in ALAB. GK Wealth Management LLC acquired a new position in shares of Astera Labs during the third quarter valued at about $29,000. Cadent Capital Advisors LLC bought a new stake in shares of Astera Labs in the third quarter valued at about $1,845,000. Farther Finance Advisors LLC grew its position in Astera Labs by 102.8% during the third quarter. Farther Finance Advisors LLC now owns 6,043 shares of the company's stock worth $2,151,000 after buying an additional 3,063 shares in the last quarter. CoreCap Advisors LLC grew its position in Astera Labs by 21.0% during the third quarter. CoreCap Advisors LLC now owns 749 shares of the company's stock worth $267,000 after buying an additional 130 shares in the last quarter. Finally, Cooper Financial Group acquired a new stake in Astera Labs during the third quarter worth about $203,000. 60.47% of the stock is currently owned by institutional investors.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.